The forecasted sales of Peptic Ulcer and GORD medicines in Italy from 2024 to 2028 indicate a gradual decline in consumption. The data shows a decrease from 2024's value of 19 to 17.9 by 2028. These figures are expressed in US Dollars PPP per capita. Compared to 2023, forecasted sales are trending downward, reflecting a continuous year-on-year decline with an average annual decrease, or CAGR, over five years.

Future trends to watch for include:

Innovations in alternative therapies which may impact traditional medicine sales.
Changes in healthcare policies influencing drug pricing and accessibility.
Demographic shifts such as an aging population potentially altering demand patterns.